Delivery Order SPE2DB22D1017-SPE2DB25FF3QG
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of Tobramycin 300 mg/5 ml ampules, a specialty pharmaceutical product, with a total potential value of $2,037.22. The contract has a period of performance through January 26, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery...
This is a delivery order issued under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for 4,565,218 units of Tobramycin 300 mg/5 ml ampules, a specialty medication, at a firm fixed price of $1,258.06. The contract has a period of performance through July 23, 2024 and does not have any set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Tobramycin 300 mg/5 ml ampules in 5 ml units. It is a firm fixed-price contract with a ceiling value of $1,511.67 and an ultimate completion date of October 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,434.99 firm fixed-price delivery order is for the supply of Tobramycin 300 mg/4 ml ampules, a critical antibiotic medication. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,563,742,464 units of Tobramycin 300 mg/5 ml ampules. The contract has a ceiling value of $1,511.67 and a completion date of February 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $4,119.26 firm fixed price contract is for the supply of 4,558,749,565 units of the drug Tobramycin 300 mg/5 ml ampules. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Tobramycin 300 mg/5 ml ampules. The contract has a potential value of $4,188.53 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical products and medical supplies to support military treatment programs. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tobramycin 300 mg/5 ml ampules, a generic antibiotic medication, with a ceiling value of $9,928.88 and a period of performance through November 26, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $28,502.07 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The order is for the supply of 4,564,261,702 units of the medication Tobramycin 300 mg/4 ml ampules. The delivery order has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, also holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order, valued at $1,157.19, is for the provision of Tobramycin Pak 300 mg/5 ml, a pharmaceutical product. The delivery order has a firm fixed price structure and a completion date of January 29, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, as the prime...